Abiopharma

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

IQVIA Reports Third-Quarter 2025 Results

Castle Biosciences to Participate in Upcoming Investor Conferences

Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity

Entrada Therapeutics to Present at Upcoming Investor Conferences

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Alkermes plc Reports Third Quarter 2025 Financial Results

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

Tenet Reports Strong Third Quarter 2025 Results; Raises 2025 Financial Outlook